Dr. Griebel Claudia
About Dr. Griebel Claudia
Dr. Griebel Claudia is the Health Economics and Market Access Manager DACH at Boston Scientific, with extensive experience in market access and health economics roles across various companies.
Current Role at Boston Scientific
Dr. Griebel Claudia is currently employed at Boston Scientific as the Health Economics and Market Access Manager DACH, a position she has held since 2019. In this role, she is responsible for ensuring optimal reimbursement conditions for urology and pelvic health products. Additionally, she serves as the HEMA DACH Team expert for new NUB (new and innovative diagnostic and treatment methods) regulations and integrated care concepts.
Previous Experience at LivaNova
From 2016 to 2019, Dr. Griebel Claudia worked as the Market Access Manager DACH at LivaNova, located in München und Umgebung, Deutschland. During her three-year tenure, she focused on market access strategies and initiatives, contributing significantly to the company's growth and market penetration in the DACH region.
Role at OTSUKA Pharmaceutical S.A.
Dr. Griebel Claudia served as the Health Care Manager Deutschland at OTSUKA Pharmaceutical S.A. from 2015 to 2016. She worked on market access and healthcare management during this one-year period, ensuring the company's products achieved optimal market penetration and reimbursement conditions in Germany.
Academic Background and Education
Dr. Griebel Claudia holds advanced degrees from distinguished institutions. She achieved her Diplom Chemikerin and Dr.rer.nat. in Chemistry from Technische Universität Clausthal. Additionally, she completed her Master Studium in Epidemiology at Universität Bielefeld. Her academic background has equipped her with significant expertise and knowledge in both chemical sciences and epidemiology.
Industry Contributions and Roles
Dr. Griebel Claudia contributes to the medical technology industry through various roles. She serves as the speaker of the benefit assessment working group of BVmed (German Medical Technology Association). Her work involves addressing NUB regulations and integrated care concepts, showcasing her dedication to improving healthcare outcomes through effective market access and reimbursement strategies.